COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 MUTATIONS

• 收藏
• 分享

专利权人:

Board of Regents; The University of Texas System

发明人:

Jacqulyne ROBICHAUX,Monique NILSSON,John V. HEYMACH

申请号：

US16461992

公开号：

US20200316071A1

申请日:

2017.11.17

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present disclosure provides methods of treating cancer in a patient determined to have an EGFR and/or HER2 exon 20 mutation, such as an insertion mutation, by administering a third-generation tyrosine kinase inhibitor, such as poziotinib or afatinib.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/